Immune Responses in Pancreatic Cancer: Primary vs. Metastatic | Oncotarget

Posted by

Oncotarget

Oncotarget published this trending editorial on April 24, 2023 in Volume 14, entitled, “The critical immune basis for differential responses to immunotherapy in primary versus metastatic pancreatic cancer" by researchers from the Department of Surgery, Trinity Health of New England, Waterbury, CT. DOI - https://doi.org/10.18632/oncotarget.28373 Correspondence to - George Miller - gedalyamil@gmail.com Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28373 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, pancreatic cancer, liver metastasis, immunnotherapy About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957